Hans-Olov Adami

Hans-Olov Adami is a Professor at the Clinical Effectiveness Group within the Institute of Health and Society at the University of Oslo (since 2012). He has held prominent academic roles globally, including Chair of the Department of Epidemiology at Harvard School of Public Health (2007–2011) and Professor of Cancer Epidemiology at Karolinska Institutet (1997–2008). His career spans over three decades in epidemiology, clinical research, and cancer studies.

• Key Positions:
• Professor, University of Oslo (2012–present)
• Adjunct Professor, Harvard School of Public Health (2012–2017)
• Chair, Harvard School of Public Health’s Epidemiology Department (2007–2011)
• Member of the Nobel Committee (1998–2000) and Nobel Assembly (1998–2008)

Research Focus: His work centers on clinical cancer research, randomized control trials, cancer screening strategies, and epidemiological studies of cancer etiology and prevention. He has pioneered methodologies in population-based cancer surveillance and intervention trials.

Awards & Recognition:

• Recipient of the Big Silver Medal and Distinguished Professor Award from Karolinska Institutet (2011)
• Honorary Doctorates from the University of Iceland (2010) and University of Athens (1998)
• Member of the Swedish Royal Academy of Sciences (2007)

Leadership & Service: He has served on global health committees, including the Governing Board of the European Academy of Cancer Sciences (2010–2018) and the Scientific Strategic Committee of the ARC Foundation (2014). His contributions to cancer epidemiology have shaped international research agendas and policy.